Cargando…
Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene
Presentation of antigenic peptides by major histocompatibility complex (MHC) class I molecules requires MHC-encoded molecules of the adenosine triphosphate binding cassette (ABC) family. Defects in these proteins represent a potential risk, since they are essential links in the machinery of T cell-m...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190880/ https://www.ncbi.nlm.nih.gov/pubmed/8418201 |
_version_ | 1782146874018365440 |
---|---|
collection | PubMed |
description | Presentation of antigenic peptides by major histocompatibility complex (MHC) class I molecules requires MHC-encoded molecules of the adenosine triphosphate binding cassette (ABC) family. Defects in these proteins represent a potential risk, since they are essential links in the machinery of T cell-mediated surveillance which continuously scrutinizes peptide samples of cellular proteins. Nevertheless, transfection of the mouse lymphoma mutant RMA-S with the rat ABC gene mtp2a (homologue to mouse HAM2 and human RING11), commonly termed TAP-2 genes, led to a marked increase in tumor outgrowth potential in vivo. This occurred despite restored antigen presentation and sensitivity to cytotoxic T lymphocytes, and was found to be due to escape from natural killer (NK) cell-mediated rejection. It has previously been proposed that adequate expression of self-MHC class I is one important mechanism to avoid elimination by NK cells. Our data argue that a defect in the machinery responsible for processing and loading of peptides into MHC class I molecules is sufficient to render cells sensitive to elimination by NK cells. The latter thus appear to function as a surveillance of the peptide surveillance machinery. |
format | Text |
id | pubmed-2190880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1993 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21908802008-04-16 Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene J Exp Med Articles Presentation of antigenic peptides by major histocompatibility complex (MHC) class I molecules requires MHC-encoded molecules of the adenosine triphosphate binding cassette (ABC) family. Defects in these proteins represent a potential risk, since they are essential links in the machinery of T cell-mediated surveillance which continuously scrutinizes peptide samples of cellular proteins. Nevertheless, transfection of the mouse lymphoma mutant RMA-S with the rat ABC gene mtp2a (homologue to mouse HAM2 and human RING11), commonly termed TAP-2 genes, led to a marked increase in tumor outgrowth potential in vivo. This occurred despite restored antigen presentation and sensitivity to cytotoxic T lymphocytes, and was found to be due to escape from natural killer (NK) cell-mediated rejection. It has previously been proposed that adequate expression of self-MHC class I is one important mechanism to avoid elimination by NK cells. Our data argue that a defect in the machinery responsible for processing and loading of peptides into MHC class I molecules is sufficient to render cells sensitive to elimination by NK cells. The latter thus appear to function as a surveillance of the peptide surveillance machinery. The Rockefeller University Press 1993-01-01 /pmc/articles/PMC2190880/ /pubmed/8418201 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title | Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title_full | Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title_fullStr | Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title_full_unstemmed | Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title_short | Tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
title_sort | tumorigenicity conferred to lymphoma mutant by major histocompatibility complex-encoded transporter gene |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2190880/ https://www.ncbi.nlm.nih.gov/pubmed/8418201 |